GlassScriptPhysician profile
John P Lamond
NPI 1982697371
$1,735.69
in general payments reported to CMS, 2019-2025
26 companies · $74.86 in 2025
The $74.86 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $708 · 2020: $201 · 2021: $150 · 2022: $487 · 2023: $84.73 · 2024: $31.00 · 2025: $74.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $190.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $314.62 | 2019-2023 | Lynparza, Imfinzi |
| Galvanize Therapeutics, INC | $152.02 | 2022 | |
| Puma Biotechnology, INC. | $145.03 | 2019-2020 | |
| Novocure INC. | $141.89 | 2022-2025 | Optune Gio |
| Sirtex Medical INC | $140.21 | 2019 | |
| Eisai INC. | $91.80 | 2019-2020 | |
| Myovant Sciences INC. | $84.10 | 2021-2022 | |
| Kyowa Kirin, INC. | $73.91 | 2019-2020 | |
| Tesaro, INC. | $73.55 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $73.34 | 2019 | |
| Janssen Biotech, INC. | $71.74 | 2019-2020 | |
| Celgene Corporation | $48.97 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $46.63 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $34.75 | 2019 | |
| Accuray Incorporated | $31.38 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $31.00 | 2024 | Somatom Go.Top |
| Sumitomo Pharma America, INC. | $29.49 | 2023 | Orgovyx |
| Abbott Laboratories | $22.47 | 2022 | |
| Genzyme Corporation | $18.98 | 2022 | |
| Progenics Pharmaceuticals, INC. | $18.69 | 2022 | |
| G1 Therapeutics, INC. | $17.67 | 2023 | Cosela |
| Foundation Medicine, INC. | $16.99 | 2020 | |
| Pharmacyclics LLC, An Abbvie Company | $14.94 | 2020 | |
| Myriad Genetic Laboratories, INC. | $14.90 | 2022 | |
| Blueprint Medicines Corporation | $14.49 | 2022 | |
| Spectrum Pharmaceuticals INC. | $12.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lamond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.